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Abstract
Background: Premature cervical remodeling/ripening is believed to contribute to preterm delivery (PTD), the leading cause
of perinatal morbidity and mortality. Despite considerable research, the causes of term and PTD remain unclear, and there is
no effective treatment for PTD. We previously demonstrated that complement activation plays a causative role in cervical
remodeling that leads to PTD in mice.
Methodology/Principal Findings: Here we found that complement activation is not required for the physiological process
that leads to term delivery in mice. Neither increased C3 cervical deposition nor increased C3a and C5a serum levels were
observed at term. In addition, macrophages infiltration was found in PTD in contrast to term delivery were no leukocytes
were found. Despite the different role of complement and different cellular effector cells, PTD and term delivery share a
common dowsntream pathway characterized by increased metalloproteinases (MMPs) release and increased collagen
degradation. However, different sources of MMPs were identified. Macrophages are the source of MMPs in PTD while
cervical fibroblasts and columnar epithelial cells synthesize MMPs at term delivery. A dramatic diminution in serum
progesterone levels precedes parturition at term but not in PTD, suggesting that progesterone withdrawal initiates cervical
remodeling at term. On the other hand, MMPs release in PTD is triggered by C5a.
Conclusion and Significance: In conclusion, preterm and term cervical remodeling occur through the same mechanism but
they are initiated by different mediators and effector cells. That complement activation is required for PTD but not for the
physiological process that leads to term delivery, suggests that complement is a potential specific biomarker and selective
target to prevent PTD and thus avert neonatal mortality and morbidity.
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Introduction
The process of parturition has been extensively studied.
However, the mechanisms responsible for the onset and
progression of labor are multifactorial and not completely
understood [1–3]. Understanding the mediators and effectors of
labor could have enormous benefit, allowing potential interven-
tions for efficient induction of labor or conversely in postponing
unwanted labor. Identification of targets to regulate or terminate
labor is of particular importance in the treatment and prevention
of preterm labor, which continues to be a major public health issue
and the number one cause of neonatal death. Among the
important events contributing to labor is the ripening/ remodeling
of the cervix [4–6]. Changes in the cervical structure soften and
dilate the cervix allowing the passage of the fetus forced by
rhythmic myometrial contractions. We previously demonstrated
that complement activation plays a crucial role in the cervical
remodeling process that leads to preterm labor [7]. Using a mouse
model of PTD induced by LPS we found that complement split
product C5a attracts and activates macrophages to the cervix [7].
In response C5a, macrophages release metalloproteinases (MMPs)
that degrade collagen, increasing the cervix distensibility and
leading to PTD in mice [7].
The aim of this study is to characterize the term cervical
ripening process and compare it with preterm. Knowing that
complement activation plays a causative role in PTD in mice, we
decided to study if complement activation also plays a role in
cervical remodeling at term. If complement activation is not
involved in the physiological process that leads to term delivery we
will then have identified a possible specific and selective target to
prevent PTD and thus improve neonatal health.
Materials and Methods
Ethics Statement
Our animal studies were performed following the Russell and
Burch [8] Three R’s (Replacement, Reduction and Refinement)
concept to minimize animal use and pain or distress while still
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performed were conducted in accordance with the National
Institute of Health guidelines on laboratory animals and with
approval from the Wayne State University (protocol A 09-08-09)
and York College CUNY committee on Animal Use and Care
(protocol R-3-2009).
Animals
C57BL/6 timed-pregnant mice were purchased from Jackson
Laboratories (Bar Harbor, ME). Animals were shipped on day 10
to 12 after mating. Animals were acclimated in the animal facility
for 3 to 5 days before use in these experiments.
Cervical remodeling was studied in mice at term and during
preterm labor. A mouse model of PTD which resembles most
clinical scenarios in that localized inflammation occurs without
systemic maternal illness was used [7]. In this model, mice were
treated with LPS (E. coli serotype 055:B5 (250 mg/mouse,
intravaginally)) on day 15 of pregnancy. Most of the pregnant
females (94.7%) delivered within 24–36 hours of LPS administra-
tion [7]. No maternal morbidity or mortality was observed in this
model.
Pregnant mice treated with LPS were euthanized antepartum
(between 12–18 hours after treatment) or during delivery (intra-
partum). Delivery was considered preterm if it occurred within
48 hours after LPS administration (before gestational day 17). In
our animal facilities, term delivery occurs between day 20 and day
21 of pregnancy. Control mice were euthanized antepartum (day
17, 18 and 19) or intrapartum (by direct observation after the
passage of 1 or 2 pups). Blood samples and cervical tissue were
collected.
Serum complement activation products and
progesterone levels
To determine the role of complement activation in term and
PTD, generation of complement split products C3a and C5a were
measured by measuring the more stable metabolites C3adesArg
and C5adesArg in serum. C3a(desArg) and C5a(desARg) result
from the removal of the C-terminal arginine by ubiquitous
carboxypeptidases and have longer half time than C3a and C5a.
C3adesArg in serum was measured by sandwich ELISA as
previously described [7] using rat anti-mouse C3a and biotin rat
anti-mouse C3a. Both antibodies were purchased from BD
Biosciences Pharmingen, CA. A Standard curve was performed
using purified mouse C3a protein (native) (BD Biosciences
Pharmingen). C5adesArg was also measured by sandwich ELISA
using rat anti-mouse C5a and biotin rat anti-mouse C5a [7]. Both
antibodies and mouse purified C5a protein for the standard curve
were purchased from BD Biosciences.
Progesterone levels were measured by competitive enzyme
immune assay (Cayman Chemicals, Ann Arbor, MI).
Immunohistochemistry and immunocytochemistry
Cervical tissues isolated during antepartum and intrapartum
were frozen in O.C.T. compound, and cut into 10 mm sections.
Sections were stained for C3 with rabbit anti-mouse C3 (LifeSpan
Biosciences, Seattle, WA), neutrophils were stained with rat anti-
mouse granulocyte RB6-8C5 mAb (BD Biosciences Pharmingen)
and macrophages with F4/80 (Novus Biologicals, Inc, Little-
ton,CO). MMP-2 and MMP-9 were detected in frozen cervical
sections using rabbit polyclonal anti-mouse MMP-2 and MMP-9
antibodies (Abcam, Cambridge, MA). Collagen I distribution was
determined using Masson’s Trichrome staining and by immuno-
histochemistry using a polyclonal antibody against collagen type I
(ACRIS Antibodies, GmbH, Herford, Germany). HRP-labeled
specific secondary antibodies and DAB as substrate were used to
develop the respective reactions.
In situ zymography
Metalloproteinases MMP-2 and MMP-9 activity against
collagen I and IV and gelatin were measured by in situ
zymography as previously described [7,9]. Briefly, 10-mm-cervix
sections were washed in PBS and then incubated for 4 hours with
different MMPs DQ substrates. DQ-gelatin, DQ-collagen I and
DQ collagen IV (Invitrogen, Carlsbad, CA). The enzyme-driven
hydrolysis of these substrates results in an increase in fluorescence
signal. Increased fluorescence indicates increased gelatin and
collagen degradation by MMPs. In parallel, control sections were
preincubated with buffer containing the MMP inhibitor EDTA to
indicate the contribution of MMPs [7]. The reaction was stopped
by a 10 minutes incubation in 4% paraformaldehyde-PBS.
Finally, mounting medium supplemented with DAPI (Vector
Laboratories, Burlingame, CA) was applied. Sections (4–6 tissue
sections/group) were observed under a fluorescence microscope
Nikon Eclipse 50i (Nikon Inc, Melville, NY) and photographs were
taken using a Nikon DigiSight Color Digital Camera System and
NIS-Elements Research Imaging Software.
Human cervical epithelial cells
A cell line from normal human endocervical epithelia
immortalized by expression of human papillomavirus (Endl/
E6E7) (ATCC Manssas, VA) was used in in vitro studies [10]. The
morphology of these immortalized cells corresponds to glandular
tall columnar epithelial cervical cells and closely resembles that of
the tissue of origin and primary cultures. Thus, End1/E6E7 cells
constitute a reproducible in vitro model to study the role of these
epithelial cells in cervical ripening. End1 cells were cultured as
previously described [10]. The expression of C5aR on End-1cells
was studied by immunohistochemistry using anti-human C5aR
antibodies (Cell Sciences, Canton, MA). MMP-2, MMP-9 and
progesterone receptors (PR) expression in End-1 cells was also
evaluated by RTPCR. Aliquots of End1 cells were incubated for
16 h with progesterone (1 mg/ml) and synthesis of MMP-2 and
MMP-9 was studied by RT-PCR.
Aliquots of End1/EGE7 cells were cultured on cell chamber
slides incubated with and without progesterone (1 mg/ml) for 16 h
and then subjected to in situ zymography using DQ-gelatin and
DQ-collagen I as previously described. Immunohistochemistry
was performed to detect MMP-2 and MMP-9 using rabbit
polyclonal anti-mouse MMP-2 and MMP-9 antibodies (Abcam,
Cambridge, MA) followed by a FITC-labelled anti-rabbit antibody
(Abcam, Cambridge, MA).
Quantitative reverse transcriptase-polymerase chain
reaction (qRT-PCR)
To determine whether End1 synthesize MMP-2, MMP-9 and
PR, qRT-PCR was performed. RNA was harvested from End1
cells with RNeasy Mini Kit (Qiagen, Valencia, CA) and 1 mgo f
total RNA was reverse transcribed. Primer sequences mouse
GAPDH, human MMP-2, MMP-9 and PR were obtained from
Applied Byosystems (Foster City, CA). Relative expression was
normalized for levels of GAPDH. Relative quantification of MMP-
2 and MMP-9 between End-1 cells incubated with and without
progesterone gene expression was performed using 2
2DDCT data
analysis. The comparison was performed in pairs using the same
target gene and the same End-1 samples. CT=Threshold value;
DCT=average target CT – average GAPDH CT; DDCT (for the
Different Mediators in Term and Preterm Delivery
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terone- average DCT End-1 incubated without progesterone.
DDCT=0 when the End-1 of interest are used as calibrator.
2
2DDCT=normalized target gene amount (MMP-2 or MMP-9)
relative to target gene amount in End-1 cells incubated without
progesterone. * p,0.05, n=4.
Results
Serum progesterone levels in term and preterm delivery
In most mammalian species aside from the great apes, labor is
initiated by a decrease in circulating progesterone levels
(progesterone withdrawal) [11]. Indeed, we found that in mice,
serum progesterone levels drop dramatically intrapartum when
compared to antepartum levels (Fig. 1). On the other hand, mice
treated with LPS that deliver preterm do not show a diminution in
progesterone levels compared to antepartum levels. Progesterone
levels in antepartum were comparable to intrapartum values in
LPS-treated mice (Fig. 1), suggesting that progesterone withdrawal
is not involved in preterm parturition in LPS-treated mice.
Complement activation in term and preterm delivery
Complement activation involves the cleavage of C3 into C3b
that deposits on the tissue, and C3a that can be measured in
systemic circulation. Increased C3 deposition was observed in the
cervix of LPS-treated mice during antepartum and intrapartum
(Fig. 2A). Prompted by the findings that complement activation
triggers cervical remodeling and preterm labor (Fig. 2A) [7], we
investigated if complement activation also contributes to term
labor. Surprisingly, no C3 cervical deposition was observed in
mice that delivered at term (Fig. 2B). Negative staining for C3b
was observed in cervical samples collected antepartum (days 17, 18
and 19) or intrapartum (Fig. 2B). In addition, mice that delivered
at term showed no increase in serum C3a and C5a levels, neither
antepartum nor intrapartum (Fig. 2C and 2D). C3a and C5a levels
in mice that delivered at term were significantly lower than those
observed in mice that delivered preterm (Fig. 2C and 2D). The
absence of complement split products at term labor suggests that
complement activation is not involve in the physiological process
that leads to term parturition.
Inflammatory cells in term and preterm delivery
We previously demonstrated that inflammation plays a crucial
role the cervical remodeling that leads to PTD [7]. To determine
whether inflammatory cells are also required for the cervical
ripening at term, we performed immunohistochemical studies in
cervical samples harvested antepartum and intrapartum in control
untreated mice. The presence of macrophages was studied using
antibodies against F4/80 and neutrophils were identified with
antibodies anti-Gr1. Increased macrophages were observed
antepartum and intrapartum in the cervix of mice that deliver
preterm (Fig. 3) [7]. In contrast, no macrophages were observed in
samples collected antepartum and intrapartum at term (Fig. 3).
The absence of inflammatory cells indicates that the cervical
remodeling that leads to term labor is not dependent on
leukocytes. That inflammatory cells do not participate in the
cervical changes that contribute to term labor constitute a
significant difference between the term and preterm mechanisms
of labor.
Staining with anti-Gr1 showed that neutrophils are not present
neither n the cervix of mice at term nor at preterm (Fig. 3) [7].
MMPs synthesis in human cervical columnar epithelial
cells End1
MMPs participate in cervical remodeling by degrading the
network of collagen fibers and thus increase the distensibility
required for delivery [12,13]. It has been extensively documented
that inflammatory cells, macrophages and neutrophils, are a good
source of MMPs. The absence of inflammatory cells in the cervical
tissue at term leads as to investigate other possible sources of
MMPs. In the absence of inflammatory cells, cervical columnar
epithelial and stromal fibroblastic cells could be alternative sources
of MMPs. To determine whether cervical columnar epithelial cells
are capable of synthesizing MMPs, we performed qRT-PCR.
MMP-2 and MMP-9 mRNA was found in End-1 cells (Fig. 4B),
indicating that cervical columnar epithelial cells can be a source of
MMPs in cervical remodeling at term. In situ zymography studies
show that End-1 cells produce and release proteases that digest
gelatin and collagen I (Fig. 4C). These active proteases were
identified as MMP-2 and MMP-9 by immunohistochemistry
(Fig. 4C).
Figure 1. Serum progesterone levels in PTD and term delivery. Antepartum LPS serum samples were collected at day 15 of pregnancy,
intrapartum LPS samples at days 16 and 17, antepartum term samples at days 17, 18 and 19 and intrapartum term at days 20 and 21. Note that
progesterone levels drop dramatically near parturition time (days 20 and 21) in control mice at term while LPS-treated mice that delivered preterm
did not show changes in progesterone levels. * Different from antepartum, P,0.05. 3 to 5 samples were analyzed at each time point.
doi:10.1371/journal.pone.0026877.g001
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C5aR could not be detected on End-1 cells by immunohisto-
chemistry (Fig. 4A). The absence of C5aR in End-1 cells suggests
that cervical columnar epithelial cells are not cellular effectors in
PTD, a complement-dependent process. Indeed, we previously
described that macrophages rich in C5aR are the main source of
MMPs in PTD [7].
In addition, we found that End-1 cells express progesterone
receptor (PR) at the mRNA level. Interestingly, progesterone that
inhibited MMP release from macrophages in PTD [7] inhibits the
synthesis of MMP-2 and MMP-9 in these cells (Fig. 4B). In
agreement with these results, we were able to detect progesterone
receptors (PR) 19 and 20 in mouse cervical epithelial cells by
immunohistochemistry. As shown in Figure 4D, positive staining
for PR-19 and PR-20 was observed in the cervical columnar
epithelium at term.
We also explored the possibility that cervical fibroblastic cells
express MMPs. In accordance to our hypothesis, we found positive
staining for MMP-9 in the fibroblasts stroma harvested antepar-
tum in mice that deliver at term (Fig. 4E). Thus, cervical stromal
fibroblastic cells can be another source of MMPs leading to
cervical remodeling and parturition at term. In addition, we
measured MMP-2, another proteolytic enzyme involved in
cervical remodeling. We detected MMP-2 in the epithelium and
stroma antepartum and intrapartum at term (Fig. 4F). We were
not able to detect MMP-2 expression in the cervical tissue of mice
that deliver preterm (data not shown).
Cervical MMPs and collagen degradation in term and
preterm delivery
MMPs degrade collagen in the cervix and prepare it for dilation
and delivery [12,13]. Regardless the different sources of MMPs in
preterm and term, remodeling of the cervix and massive collagen
degradation was observed antepartum and intrapartum in both
term and preterm delivery (Fig. 4G). Masson’s trichrome (TC)
staining revealed a loose array of disordered collagen fibers in the
cervix of mice that deliver preterm and term (Fig. 4G).
Immunohistochemical studies with specific antibodies against
mouse collagen I showed a similar distribution pattern of collagen
(Fig. 4G). Collagen packing was disorganized, collagen fibers
looked thinner and greater spacing between fibers were observed
both antepartum and intrapartum in mice that delivered at term
and preterm (Fig. 4G).
Decreased density in collagen fibers was associated with
increased expression of MMP-9 (Fig. 4G). In situ zymography
using DQ collagen I as substrate revealed an increase in
collagenolytic activity in the cervix of mice that deliver at term
and preterm (Fig. 4G).
Figure 2. Complement activation in PTD and term delivery. A- Complement C3 deposition in the cervix of mice that delivered preterm
antepartum and intrapartum. Black arrows point to complement deposition in the cervical columnar l epithelium (CE). Original magnification is620.
B- Complement C3 deposition in the cervix of mice that deliver at term. C3 deposition was not observed antepratum (days 17, 18 and 19) or
intrapartum. Original magnification is620. For C3 determination, 4 slides per animal were stained and 6–8 animals were studied in each group. C–D
C3adesArg and C5adesArg levels in serum from mice with PTD and term delivery collected antepartum and intrapartum. Antepartum LPS serum
samples were collected at day 15 of pregnancy, intrapartum LPS samples at days 16 and 17, antepartum term samples at days 17, 18 and 19 and
intrapartum term at days 20 and 21. * Statistically different from control, p,0.05. n=5–6 mice/group.
doi:10.1371/journal.pone.0026877.g002
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Is cervical remodeling in PTD caused by the same mechanism/s
that cause/s cervical remodeling at term but these changes are
accelerated in time? This question has been pondered by
obstetricians seeking for strategies to prevent PTD for many
years. To answer this question we investigated the initiators and
cellular effectors in a mouse model of preterm delivery and in
control mice that delivered at term. We previously described that
complement activation plays a causative role in PTD in mice [7].
Thus, we sought to investigate if complement activation also plays
a role in cervical remodeling at term. Here we found that
complement activation is not involved in the physiological process
that leads to term delivery suggesting that we identified a possible
specific and selective target to prevent PTD. In addition, serum
complement C3a and C5a levels, that increased during PTD did
not increase in mice that deliver at term. That C3a and C5a
increase only during PTD suggests that they can be potential
biomarkers. This is in agreement with several clinical studies that
demonstrate a potential role of complement split products as
biomarkers of PTD [14–16].
Recent studies in mice suggested that the mechanisms of
cervical remodeling in preterm birth is different from normal
ripening at term [17,18]. In one of these studies the expression of
proinflammatory genes is upregulated in preterm birth compared
to term [17]. The other study demonstrated that cervical ripening
preterm can be initiated by more than one mechanism and it is not
necessarily an acceleration of the physiological process at term
[18].
Our data suggest that the cervical ripening at term is a process
non-leukocyte dependent. We did not find inflammatory cells in
the cervix of mice with term parturition in contrast to mice that
delivered preterm [7]. Several animal studies support our
observation that cervical remodeling at term is leukocyte-
independent. Steroid 5alpha-reductase type 1 null mice
(Srd5a12/2) that do not recruit inflammatory cells in the cervix
give birth normally suggesting that inflammatory cells are not
required for term parturition [19]. In addition, granulocyte
depletion with monoclonal antibodies LyG (Gr1) before birth
has not effect on the timing or outcome of parturition in mice [19].
A human study emphasizes the lack of correlation between
inflammation and cervical remodeling at term. In this study, the
authors reported that inflammation-related genes did not emerge
as differentially express with cervical ripening [20]. Even though
several studies in animals suggest that inflammatory cells do not
participate in cervical ripening at term, some human studies
suggest that inflammatory cells do participate in the cervical
changes in term parturition [21,22]. This discrepancy might be
caused by the fact that when the biopsies are obtained;
intrapartum may overlap with postpartum and the cervical repair
process might have already started. Indeed many studies
demonstrate the crucial role of inflammatory cells in the cervical
tissue repair after delivery [19].
We previously demonstrated that complement component C5a
recruits and activates macrophages in cervical tissue leading to
cervical ripening and PTD in LPS-treated mice [7]. The absence
of complement activation and generation of C5a in cervical tissue
at term might explain the absence of inflammatory cells. Despite
the absence of complement activation and inflammatory cells at
term, our data demonstrate the presence of MMPs and
concomitant collagen degradation in the cervix of mice that
deliver at term and preterm. Increased expression of MMP-9,
disorganized collagen packing, thinner collagen fibers and greater
spacing between fibers were observed in both term and preterm.
This suggests the existence of a common downstream pathway
shared by term and preterm cervical remodeling.
The identification of this common mechanism raises the
question as to which cells are responsible for MMP release during
cervical ripening at term. It has been established that cervical
fibroblasts obtained from pregnant women are capable of releasing
MMPs in culture [23]. Other studies also showed that human
cervical fibroblasts can also synthesize MMPs [24,25]. In addition,
Figure 3. Inflammatory cells in cervical tissue from mice that deliver preterm and at term. A- F4/80 staining in cervical tissue. Increased
macrophage infiltration (black arrows) was observed in the cervix of mice that deliver preterm antepartum and intrapartum. In contrast no
macrophages were observed in the cervix of mice that deliver at term antepartum and intrapartum. Original magnification is620. B- Gr-1 staining in
cervical tissue. No neutrophil infiltration was observed at preterm or term cervical samples. Original magnification is 620. 4 slides per animal were
stained and 6–8 animals were studied in each group.
doi:10.1371/journal.pone.0026877.g003
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from rabbits synthesize MMP-9 in culture [24]. Indeed, we found
positive staining for MMP-9 in cervical fibroblastic cells in the
stroma of control mice at term.
Staining for MMP-9 and robust activity against collagen I was
also observed in the cervical columnar epithelium in mice at term.
Thus, we performed in vitro studies using End-1 cells [10] (human
columnar epithelial cells) to corroborate that these cells can indeed
synthesize and express MMPs. qRT-PCR studies revealed the
presence of MMP-2 and MMP-9 mRNA and in situ zymography
and immunohistochemistry studies demonstrate the presence of
active MMP-2 and MMP-9 in End-1 cells, suggesting that
columnar epithelial cells can be the source of MMPs responsible
for cervical remodeling that leads to parturition at term.
We also need to consider that cytokines secreted by the
myometrium, placenta and fetal membranes at term contribute to
the release of MMPs in the cervix in the absence of inflammatory
cells [26,27]. Thus, it is possible that inflammatory mediators
secreted by neutrophils infiltrating the fetomaternal interface reach
the cervical stroma and promote MMPs release.
It has been described that progesterone inhibits the release of
MMPs and collagenolysis [28,29]. Interestingly, we found that
progesterone inhibits the synthesis and expression of MMP-2 and
MMP-9 in End-1 cells. That progesterone inhibits MMPs release
suggests that a diminution in progesterone levels might trigger the
release of MMPs and induce cervical ripening at term. Indeed, we
found that progesterone levels drop dramatically in mice around
parturition time at term, in contrast to mice that deliver preterm.
Figure 4. Cervical MMPs activity and collagen degradation at PTD and term delivery. A- Immunohistochemical determination of C5aR in
End-1 cervical columnar epithelial cells. n=4. B– Relative quantification of MMP-2 and MMP-9 between End-1 cells incubated with and without
progesterone. * p,0.05, n=4 mice/group. Note that in End-1 cells incubated with progesterone a ,50% reduction in MMP-2 and MMP-9 mRNA was
observed when compared to untreated cells. C- In situ zymography using substrates DQ-gelatin and DQ-collagen I and immunohistochemical
detection of MMP-2 and MM9-9 en End-1 cells incubated with and without progesterone. The green fluorescence indicate the substrate has been
digested. MMP-2 and MMP-9 were detected by IHC using specific antibodies followed by FITC-labeled secondary antibodies. D-
Immunohistochemical detection of progesterone receptors PR-19 and PR-20 in the cervix of mice during antepartum at term. 4 slides per animal
were stained and 6–8 animals were studied in each group. E- Trichrome staining, staining for collagen I and for MMP-9 and in situ zymography using
DQ-collagen I in cervical tissue harvested antepartum and prepartum from mice that deliver preterm and at term. 3–4 slides per animal and 5 to 6
mice/group were used for immunohistochemical studies. Original magnification is620. F- Immunohistochemical determination of MMP-9 in cervical
stromal fibroblasts at term. 4 slides per animal were stained and 6–8 animals were studied in each group. G- Immunohistochemical determination of
MMP-2 in cervical columnar epithelial and stromal cells at term during antepartum and intrapartum. 4 slides per animal were stained and 6–8 animals
were studied in each group.
doi:10.1371/journal.pone.0026877.g004
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MMPs release and subsequent parturition at term as has been
suggested [11]. We were not able to detect C5aR on End-1 cells,
suggesting that complement activation that is responsible for the
release of MMP-9 from macrophages in PTD is not involved in
MMP release from cervical columnar epithelial cells. Thus, we
propose that progesterone withdrawal triggers MMPs release and
parturition at term. That progesterone receptors PR-19 and PR-
20 are present in cervical epithelial cells reinforces this concept.
In Figure 5 we summarize the distinct and similar features that
characterize cervical remodeling at preterm and term. 1) Preterm
delivery is initiated by complement activation while complement
activation is not required for term parturition. 2) Term delivery was
found to be non-leukocyte dependent while on the other hand PTD
is mediated by macrophages. 3) Macrophages are the source of
MMPs in PTD while cervical stromal fibroblasts and columnar
epithelial cellsseemto beresponsiblefortheproduction ofMMPsin
cervical remodeling at term. 4) The trigger for MMPs release is C5a
in PTD while our studies and other studies [11] suggested that
progesterone withdrawal is the initiator of cervical ripening at term.
Regardless the different triggers and cellular mediators, we
identified a common downstream pathway that involves MMPs
release and collagen degradation in both term and PTD.
In conclusion, preterm and term cervical remodeling occur
through the same mechanism but they are initiated by different
triggers and effector cells. Thus, we demonstrated that preterm
birth is not an acceleration of the normal physiological cervical
processes that lead to term parturition.
This is the first study to identify the complement system as a
potential biomarker and possible specific and selective target for
therapy in PTD.
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